Bulletin
Investor Alert

Topics

Science and Technology

5:13 a.m. Oct. 19, 2021 - By Tomi Kilgore
Energous stock rockets on heavy volume after FCC approves 'over-the-air' wireless charging product at any distanceShares of Energous Corp. rocketed 30% on massive volume in premarket trading Tuesday, after the over-the-air wireless charging company said the U.S. Federal Communications Commission granted equipment authorization for wireless power transfer at any distance. Trading volume ballooned to 16.5 million shares, enough make the stock the most actively traded ahead of the open, and compares with the full-day average of about 720,300 shares. Energous said the FCC approval adds to the approval in Europe for unlimited distance wireless charging. "The 1W Active Energy Harvesting transmitter can charge multiple devices at once, enabling at-any-distance over-the-air charging for the growing ecosystem of Internet of Things devices such as retail sensors, electronic shelf labels, industrial devices and more," the company said. The stock has gained 11.1% year to date through Monday, while the S&P 500 has advanced 19.5%.
3:54 a.m. Oct. 6, 2021 - By Tomi Kilgore
GM and GE agree to develop supply chains to support EV production, renewable energy growthGeneral Motors Co. and General Electric Co. said Wednesday that they signed a memorandum of understanding (MOU) to improve supplies of rare earth materials, magnets, copper and electrical steel used in making electric vehicles and renewable energy equipment. The automaker and industrial conglomerate will first focus on creating a North America- and Europe-based supply chain for magnet manufacturing, and will then collaborate on establishing new supply chains for additional materials, such as copper and eSteel. "A secure, sustainable and resilient local supply chain for electric vehicle materials is critical to the execution of GM's vision of an all-electric future," said Shilpan Amin, GM's vice president for global purchasing and supply chain. "Working with GM gives us another tool to obtain a reliable, sustainable, and competitive source of key materials going forward that will help us lower the cost of renewable energy and drive more electrification by making EVs a more viable option for consumers," said GE Renewable Energy Chief Technology Officer Danielle Merfeld. GE's stock fell 1.6% in premarket trading Wednesday and GM shares fell 0.5%, while futures for the S&P 500 shed 1.1%.
7:22 a.m. Oct. 5, 2021 - By Jaimy Lee
E.U. authorizes third dose of Moderna's COVID-19 vaccine for the immunocompromisedShares of Moderna Inc. gained 1.2% in trading on Tuesday after the company announced that the European Medicines Agency authorized a third dose of its COVID-19 vaccine for people who are severely immunocompromised. The authorization applies to those who are least 12 years old who have waited at least 28 days since getting their second dose of the vaccine. The U.S. authorized a third of the Moderna and BioNTech /Pfizer Inc. vaccines for the immunocompromised people . Moderna's stock is up 216.1% so far this year, while the broader S&P 500 has gained 14.7%.
7:49 a.m. Aug. 16, 2021 - By Tomi Kilgore
Pfizer, BioNTech submit trial data on COVID-19 booster shot to FDAPfizer Inc. and partner BioNTech SE announced Monday that data from a Phase 1 study has been submitted to the U.S. Food and Drug Administration, for the evaluation of a third, booster dose of their COVID-19 vaccine. The companies said they will also submit the data to the European Union's version of the FDA, the European Medicines Agency, as well as other regulatory authorities, in the coming weeks. In the U.S., Pfizer-BioNTech plan to seek licensure of a third dose in people at least 16 years old. Last week, for some people with compromised immune systems. "This initial data indicate that we may preserve and even exceed the high levels of protection against the wild-type virus and relevant variants using a third dose of our vaccine," said BioNTech Chief Executive Ugur Sahin. "A booster vaccine could help reduce infection and disease rates in people who have previously been vaccinated and better control the spread of virus variants during the coming season." Shares of Pfizer slipped 0.6% in midday trading and BioNTech's stock dropped 10.6%, while the S&P 500 eased 0.4%.
5:29 a.m. June 21, 2021 - By Jaimy Lee
Day One Biopharma's experimental glioma drug gets an orphan designation in EuropeShares of Day One Biopharmaceuticals Inc. gained 9.4% in premarket trading on Monday after the company said its experimental glioma treatment received an orphan designation in Europe. The drug candidate has already received a Breakthrough Therapy designation from U.S. regulators for one indication and an orphan designation as a treatment for malignant glioma. In the U.S., an orphan-drug designation supports developing treatments for diseases that affect fewer than 200,000 people. Gliomas are a type of nervous system tumor. Day One last month.
2:25 a.m. April 12, 2021 - By Tomi Kilgore
Coronavirus tally: Global deaths from COVID-19 climb toward 3 million, as U.S. death toll tops 562,000The global tally for the coronavirus-borne illness rose to 136.1 million on Monday, according to , as the death toll climbed to 2,937,730. The U.S. leads the world in cases and deaths by wide margins, with 31.2 million cases, or about 23% of the global total, while the 562,066 death toll made of about 19% of the total. On Sunday, the U.S. added at least 48,147 new cases and 296 new deaths, , although those numbers are likely under-reported given reduced staffing at hospitals at weekends. The U.S. has averaged 69,632 cases per day, up 11% from the average two weeks ago. The rise in new cases comes despite the continued increase in vaccinations. More than 187.0 million doses have been administered and more than 119.2 million Americans -- 35.9% of the total population -- have received at least one dose, with more than 72.6 million people, or 21.9% of the population, being fully vaccinated, according to (CDC). Outside of the U.S., Brazil is second globally in cases at 13.53 million and also second with a death toll of 353,137. India is third worldwide in cases with 13.48 million and fourth in deaths at 170,179. Mexico is third by deaths at 209,338 and 14th highest by cases at 2.3 million. The U.K. has 4.38 million cases and 127,331 deaths, the highest in Europe and fifth highest in the world.
2:19 a.m. March 19, 2021 - By Tomi Kilgore
Coronavirus tally: U.S. daily case count climbs above 60,000, as the total count approaches 30 millionWhile COVID-19-related restrictions continue to be lifted, the daily number of confirmed cases of the coronavirus that causes COVID-19 has increased for a third-straight day. There were at least 60,782 new cases on Thursday, according to , up from 58,856 on Wednesday, while the daily death toll increased to at least 1,549 from 1,177 the day before. The global tally rose to 121,848,070 as of Friday morning, according to , with the U.S. accounting for 24.3% of the cases with 29,667,305. The global death toll grew to 2,692,244, with the U.S. toll of 539,698 accounting for 20.0%. On the vaccine front, the showed that 151,108,445 vaccine doses have been delivered and 115,730,008 doses have been administered. There have been 75,495,716 people, or 22.7% of the U.S. population, who have received at least one vaccine dose, while 40,981,464 people, or 12.3% of the population, have been fully vaccinated. Outside of the U.S., Brazil is second globally in cases at 11,780,820 and also second with a death toll at 287,499. India is third worldwide in cases with 11,514,331 and fourth in deaths at 159,370.
2:27 a.m. March 18, 2021 - By Tomi Kilgore
Coronavirus tally: U.S. daily case count rises to nearly 59,000, while deaths slip to less than 1,200The global tally for confirmed cases of the coronavirus that causes COVID-19 climbed to 121,256,160 as of Thursday morning, according to , with the U.S. accounting for 24.4% of the cases with 29,607,486. The global death toll grew to 2,681,790, while the U.S. death count rose to 538,087, or 20.1% of the worldwide total. In the U.S., new cases rose to at least 58,856 on Wednesday, according to , from 54,437 on Tuesday, while the number of deaths slipped to 1,177 from 1,245. On the vaccine front, the latest showed that 147,590,615 vaccine doses have been delivered and 113,037,627 doses have been administered. There have been 73,669,956 people, or 22.2% of the U.S. population, who have received at least one vaccine dose, while 39,989,196 people, or 12.0% of the population, have been fully vaccinated. Outside of the U.S., Brazil is second globally in cases at 11,698,838 and also second with a death toll at 284,775. India is third worldwide in cases with 11,474,605 and fourth in deaths at 159,216.
2:23 a.m. March 17, 2021 - By Tomi Kilgore
Coronavirus tally: Daily U.S. deaths rise above 1,200 as new cases slipThe global tally for confirmed cases of the coronavirus that causes COVID-19 climbed to 120,745,792 as of Wednesday morning, , with the U.S. accounting for 24.5% of the cases with 29,549,556. The global death toll grew to 2,671,764, while the U.S. death count rose to 536,922, or 20.1% of the worldwide total. On Tuesday, the number of new cases fell to at least 54,437 from 57,081 on Monday, while deaths increased to 1,245 people from 751 the day before, . For vaccines, show that 142,918,525 vaccine doses have been delivered and a total of 110,737,856 doses have been administered. There have been 72,135,616 people who have received at least one dose, or 21.7% of the population, and 39,042,345 people, or 11.8% of the population, have been fully vaccinated. Outside of the U.S., Brazil has the second highest death toll at 282,127 and is second by cases at 11,603,535. India is third worldwide in cases with 11,438,734 million and fourth in deaths at 159,044.
2:28 a.m. March 16, 2021 - By Tomi Kilgore
Coronavirus tally: U.S. daily case and death tally edges up, but average for the week falls 18%The global tally for confirmed cases of the coronavirus that causes COVID-19 climbed to 120,273,942 on Tuesday, according to , with the U.S. accounting for nearly one-quarter of the cases with 29,495,422. The global death toll grew to 2,662,067, while the U.S. death count rose to 535,628, or one-fifth of the worldwide total. On Monday, new cases increased to at least 57,081 from 38,034 on Sunday, and deaths rose to at least 751 people from 572 the day before, . The daily average of new cases over the past week was 55,153, down 18% from the average two weeks earlier. On the vaccine front, the show that 135,847,835 vaccine doses have been delivered, while 109,081,860 arms have been jabbed, including 71,054,445 people who have received at least one dose and 38,335,432 people who have been fully vaccinated. Outside of the U.S., Brazil has the second highest death toll at 279,286 and is second by cases at 11,519,609. India is third worldwide in cases with 11,409,831 million and fourth in deaths at 158,856. Mexico has the third highest death toll at 194,944 and 13th highest case tally at 2,167,729. The U.K. has the fifth-most cases at 4,276,840, while the death toll of 125,817 is fifth highest in the world and the highest in Europe.
4:02 a.m. Feb. 12, 2021 - By Jaimy Lee
CureVac's stock is up 6% as it begins regulatory process for its COVID-19 vaccine in the E.U.Shares of CureVac gained 6.0% in premarket trading on Friday after the company said it started a rolling submission for its experimental mRNA-based COVID-19 vaccine in the European Union. The vaccine is currently being tested in a Phase 3 clinical trial in Europe and Latin America. CureVac's stock has soared 64.4% over the past three months, while the S&P 500 is up 9.6%.
11:04 a.m. Feb. 1, 2021 - By Jaimy Lee
Bank of America downgrades Moderna stock over concerns about valuationShares of Moderna Inc. tumbled 8.2% in trading on Monday after Bank of America analysts downgraded the company's stock to underperform from neutral, citing valuation concerns. Until December, Moderna was a clinical-stage company that had yet to bring to market a single therapy, but it now has one of two authorized COVID-19 vaccines in the U.S. The company's stock is up 52.7% so far this year and has soared 677.6% over the past 12 months. Moderna "shares continue to run...attaining levels that are increasingly difficult to justify on a fundamental basis," the Bank of America analysts wrote in a Feb. 1 note to investors. They estimate that Moderna's COVID-19 vaccine will have about 14% of the COVID-19 vaccine market in the U.S. and Europe, and it will generate peak sales of $12.8 billion in 2022, a sales figure that is expected to decline to less than $1 billion by 2027. The emergence of two other viable COVID-19 vaccine candidates, which are being developed by Johnson & Johnson and Novavax Inc. , also cut into analyst expectations, though neither experimental vaccine has received emergency use authorization from the Food and Drug Administration or has so far reported efficacy rates as high as Moderna or BioNTech SE /Pfizer Inc.'s vaccines. "The number of vaccine options with compelling characteristics (single injection, lower cost, clean safety) could begin to weigh on Moderna's margins and market share longer-term," Bank of America analysts concluded. The S&P 500 is up 13.5% over the last 12 months.
10:33 a.m. Jan. 25, 2021 - By Ciara Linnane
Biden to reinstate travel bans amid fears about new variants as global case tally heads toward 100 million Dr. Fauci says Johnson & Johnson’s one-dose vaccine could bet emergency use authorization within two weeksThe global tally of confirmed cases of the coronavirus-borne illness COVID-19 headed closer to 100 million on Monday with the U.S. accounting for a quarter of that total, as President Joe Biden prepared to reinstate travel restrictions against foreign citizens visiting the U.S. from Brazil, the U.K, Ireland and much of the rest of Europe, as well as South Africa.
10:51 a.m. Jan. 22, 2021 - By Ciara Linnane
U.S. suffers another 4,000 deaths in a single day as experts welcome Fauci’s return to White House podium Biden calls on Americans to ‘mask up’ for the next 100 daysThe global tally for the coronavirus-borne illness COVID-19 climbed above 97.9 million on Friday and the U.S. death toll rose above 411,000, as experts welcomed the return to the White House podium of the nation’s leading infectious disease expert, after months of being sidelined by the previous administration.
8:50 a.m. Jan. 21, 2021 - By Ciara Linnane
Biden signs flurry of orders to tackle pandemic that has now cost more than 407,000 American lives Fauci addresses board of World Health Organization with promise that U.S. will join international response to crisisThe global case tally for the coronavirus-borne illness COVID-19 edged above 97 million on Thursday with the U.S. accounting for 24 million of those cases, as President Joe Biden wasted no time in implementing his plan to address a crisis that has caused the loss of more than 407,000 American lives.
9:00 a.m. Jan. 20, 2021 - By Ciara Linnane
Biden to overhaul U.S. pandemic management as death toll heads above 402,000 New president is expected to rejoin WHO, sign up for COVAX program and restore NSC-backed pandemic committeeThe global case tally for the coronavirus-borne illness COVID-19 climbed above 96.4million on Wednesday, and the U.S. death toll headed above 402,000 as President Joe Biden was inaugurated with plans to fully overhaul the U.S. approach to the pandemic.
11:02 a.m. Jan. 15, 2021 - By Ciara Linnane
Global deaths from COVID-19 top 2 million as U.S. suffers most weekly fatalities since start of the pandemic Weekly deaths exceed CDC’s estimate for flu-related deaths for entire 2019-2020 season The global case tally for the coronavirus-borne illness COVID-19 climbed above 93 million on Friday and the death toll climbed above 2 million, with the U.S. leading all nations by cases and fatalities.
10:15 a.m. Jan. 12, 2021 - By Ciara Linnane
U.S. heads toward 23 million COVID-19 cases as three lawmakers test positive after Capitol lockdown News adds to fears that last week’s attack on the U.S. seat of government created two superspreader eventsThe number of confirmed global cases of the coronavirus-borne illness COVID-19 climbed above 91 million on Tuesday, and the U.S. case tally headed toward 23 million, as three Democratic lawmakers who were forced to shelter in place during last week’s attack on the Capitol tested positive for the virus.
1:30 p.m. Jan. 11, 2021 - By Ciara Linnane
U.S. tops 22 million cases of COVID-19 after adding record of more than 300,000 in a day ‘COVID remains out of control in the U.S.,’ analyst saysThe global case tally for the coronavirus illness COVID-19 rose above 90 million on Monday, and the U.S. topped 22 million confirmed cases, after setting a record for new cases in a single day of more than 300,000 on Friday.
10:37 a.m. Jan. 8, 2021 - By Ciara Linnane
More than 4,000 U.S. lives lost to COVID in single day, exceeding death toll from 9/11 attacks Numbers exceed even worst-case scenario forecasts of health experts as vaccine rollout continues to lag targetsThe U.S. set yet another record for the number of fatalities from the coronavirus-borne illness COVID-19 and recorded the highest number of new cases since the start of the outbreak, with the latest numbers exceeding even the worst case scenario forecasts of health experts.
10:39 a.m. Jan. 7, 2021 - By Ciara Linnane
U.S. counts record of almost 4,000 COVID-19 deaths in a day as virus continues to wreak havoc Experts fear the mob that stormed the U.S. Capitol on Wednesday may have created a superspreader event as few wore face masksAs the dramatic events in Washington, D.C. were unfolding Wednesday, the coroanvirus-borne illness COVID-19 continued to wreak havoc in the U.S., claiming a record of almost 4,000 American lives, the most in a single day since the start of the outbreak.
2:15 a.m. Jan. 7, 2021 - By Ciara Linnane
U.S. could see up to 150,000 more COVID-19 deaths by February as new strain takes hold, expert warns More infectious variant makes it even more crucial to get vaccine program on track after early disappointment, says Dr. Ashish JhaThe U.S. set a fresh record for hospitalizations with the coronavirus-borne illness COVID-19 on Wednesday, as experts said the new, far more infectious variant makes it even more crucial to get the nation’s so-far underwhelming vaccine program on track.
10:19 a.m. Jan. 5, 2021 - By Ciara Linnane
January will be worst month for U.S. pandemic so far with post-holiday travel cases seen surging U.S. sets fresh record for hospitalizations and Los Angeles County says a COVID-19 patient is dying every 15 minuteshe number of global cases of the coronavirus-borne illness COVID-19 edged toward 86 million on Tuesday and the U.S. set yet another record for hospitalizations, as experts warned that January will likely be the worst month of the pandemic so far due to a surge in new infections after holiday travel.
10:56 a.m. Jan. 4, 2021 - By Ciara Linnane
U.S. heads toward 21 million COVID-19 cases and 353,000 deaths as vaccine program continues to lag all targets ‘Last mile’ vaccine distribution has been far slower than required, ‘with millions of doses still sitting on the shelves,’ says Raymond James analystThe global case tally for the coronavirus-borne illness COIVID-19 climbed above 85 million on Monday, as the U.S. headed toward 21 million cases and 353,000 deaths, as the vaccine program continued to advance with fits and starts and to lag all early targets.
7:44 a.m. Dec. 31, 2020 - By Ciara Linnane
U.S. sets record for COVID deaths, and California confirms second case of highly infectious new strain Operation Warp Speed officials acknowledge delays in distributing vaccines, experts say government must do more to help statesThe U.S. set fresh records for one-day fatalities from the coronavirus-borne illness COVID-19 and number of patients hospitalized, as California became the second state after Colorado to find a case of the new COVID-19 variant that is racing across the U.K.
10:23 a.m. Dec. 30, 2020 - By Ciara Linnane
U.S. sets record for COVID-19 hospitalizations, as country’s first case of new U.K. variant is found in Colorado Health experts continue to lament slow rollout of vaccines in U.S. after much-ballyhooed authorizations were granted in early December The U.S. set a fresh record for hospitalizations of patients with COVID-19 on Wednesday and the first case of the highly infectious U.K variant of the coronavirus was found in Colorado, as health experts continued to lament the delayed rollout of vaccines that is hampering the economic recovery.
9:44 a.m. Dec. 29, 2020 - By Ciara Linnane
WHO says coronavirus pandemic is ‘not the big one’ the world needs to brace for ‘[O]ne thing we need to take from this pandemic, with all of the tragedy and loss, is we need to get our act together. We need to honor those we’ve lost by getting better at what we do every day,’ says WHO expert.The global case tally for the coronavirus-borne illness COVID-19 climbed above 81.5 million on Tuesday, and the World Health Organization said the pandemic is not necessarily the big one that the world should brace for and urged leaders everywhere to learn from this crisis.
8:14 a.m. Dec. 24, 2020 - By Tomi Kilgore
Daily death toll from COVID-19 climbs to more than 3,400, the same day vaccinations top 1 million Daily case count rise to more than 227,000 as hospitalizations jump again to a record for the 19th day this monthThe U.S. suffered through one of its worst days on the COVID-19 front since the pandemic started, with the daily death toll jumping to more than 3,400, on the same day it reached an “early but important” milestone of more than 1 million vaccinated.
4:17 a.m. Dec. 18, 2020 - By Jaimy Lee
E.U. to buy an additional 80 million doses of Moderna's coronavirus vaccineShares of Moderna Inc. were down 0.1% in premarket trading on Friday after the company said the European Commission now plans to purchase an additional 80 million doses of its COVID-19 vaccine candidate. The commission had previously made a deal for 80 million doses. Moderna's still investigational vaccine requires two doses for each person, spaced one month apart. It has not yet been approved or authorized in any country; however, . European Union health officials are expected to decide whether to grant a conditional marketing authorization for the vaccine on Jan. 6. Moderna's stock has soared 636.2% so far this year, while the S&P 500 is up 15.2%.
10:55 a.m. Dec. 11, 2020 - By Ciara Linnane
U.S. suffers its worst week of cases, deaths and hospitalizations since the start of the pandemic CDC head warns U.S. will see more deaths every day for next few months than died on Sept. 11, 2001, or in the attack on Pearl HarborThe U.S. suffered its worst week for cases, deaths and hospitalizations with the coronavirus illness COVID-19, as the Food and Drug Administration said it would grant emergency use authorization to the vaccine developed by Pfizer Inc. and its Germany partner BioNTech SE.
10:26 a.m. Dec. 9, 2020 - By Ciara Linnane
U.S. coronavirus case tally climbs to 15 million from 14 million in just five days U.S. sets fresh record for COVID-19 hospitalizations; Angela Merkel pleads with Germans to limit gatherings during holidaysThe global case tally for the coronavirus illness COVID-19 climbed above 68 million on Wednesday and the U.S. tally rose above 15 million as the virus continued to race across the nation, filling hospitals with record numbers of patients
4:36 p.m. Dec. 8, 2020 - By Ciara Linnane
U.S. suffers deadliest week from coronavirus since pandemic broke out A group of doctors and scientists urge leaders to follow the science and stop the misinformation that has undermined the U.S. response to the crisisThe U.S. has set another grim milestone in the coronavirus pandemic, averaging the most deaths from COVID-19 in a week since the start of the outbreak, as cases continue to rise across the country and hospitals fill with patients
9:49 a.m. Dec. 7, 2020 - By Ciara Linnane
More than 101,000 COVID-19 patients are now in U.S. hospitals, and Dakotas lead nation in cases per capita ‘The vaccine’s critical. But it’s not going to save us from this current surge. Only we can save us from this current surge,’ says Dr. BirxThe U.S. set another record for hospitalizations with the coronavirus illness COVID-19 on Sunday, while case numbers and fatalities remained high, and the nation braced for what is expected to be a very dark winter.
11:00 a.m. Dec. 4, 2020 - By Ciara Linnane
CDC forecasts up to 19,500 deaths from COVID-19 in week ending Dec. 26 ‘People were less willing to change their behavior than any other day during the pandemic,’ data analyst says of Thanksgiving DayThe U.S. set yet another record for new cases and fatalities in a single day from the coronavirus illness COVID-19 and the nation’s leading public health agency said there could be up to 19,500 deaths in the week ended Dec. 26.
1:12 p.m. Dec. 3, 2020 - By Ciara Linnane
U.S. posts record one-day COVID death toll — before the predicted post-Thanksgiving surge December, January and February will be the ‘most difficult time in the public health history of this nation, largely because of the stress that it’s going to put on our health-care system,’ says CDC head Robert RedfieldThe U.S. hit some grim milestones in the coronavirus pandemic in a single day Wednesday, with a record number of fatalities and more than 100,000 COVID-19 patients in hospitals for the first time since the start of the outbreak, as a leading public health official warned of a cold, hard winter to come.
2:31 a.m. Dec. 1, 2020 - By Tomi Kilgore
Pfizer, BioNTech apply for CMA in Europe for COVID-19 vaccine candidateShares of Pfizer Inc. rallied 2.8% while Germany-based BioNTech SE dropped 2.5% in premarket trading Tuesday, after the company said they submitted their COVID-19 vaccine candidate BNT162b2 for Conditional Marketing Authorization (CMA) to the European Medicines Agency (EMA). If the EMA recommends granting a CMA, that could lead to use of BNT162b2 in Europe before the end of 2020. The companies had to the Food and Drug Administration on Nov. 20. On Monday, Moderna Inc. , and said it will apply for CMA with the EMA. Shares of Pfizer have gained 9.7% over the past three months and BioNTech's stock has rocketed 114.9%, while the S&P 500 has edged up 2.7%.
2:40 a.m. Nov. 30, 2020 - By Tomi Kilgore
Coronavirus tally: Global cases of COVID-19 near 63 million, U.S. hospitalizations hit another recordThe global tally for confirmed cases of the coronavirus that causes COVID-19 rose to 62.80 million as of early Monday, , while the death toll rose to 1.46 million. The U.S. has the highest case tally in the world at 13.39 million and the highest death toll at 266,887, or more than a fifth of the global total. The U.S. counted 136,313 new cases on Sunday, and at least 818 people died, according to . In the last week, the U.S. has averaged 162,007 cases a day, up 8% from the average two weeks ago. There were currently a record 93,219 COVID-19 patients in U.S. hospitals on Sunday, according to , topping Saturday's record of 91,635. Brazil has the second highest death toll at 171,460 and is third by cases at 6.2 million. India is second worldwide in cases with 9.43 million, and third in deaths at 137,139. Mexico has the fourth highest death toll at 105,655 and 11th highest case tally at 1.11 million. The U.K has 58,342 deaths, the highest in Europe and fifth highest in the world, and 1.62 million cases, or seventh highest in the world.
10:58 a.m. Nov. 23, 2020 - By Ciara Linnane
U.S. coronavirus case tally tops 12 million amid growing fears that Thanksgiving travel will spark another surge of infections ‘Four days before a holiday with potentially the most indoor and in-person gatherings of the year in the U.S., the virus is here and more prevalent than ever,’ says one analystThe global case tally for the coronavirus illness COVID-19 rose to 58.8 million on Monday and the U.S. tally rose above 12 million, with new daily infections heading toward 200,0000 a day amid growing fears that Thanksgiving travel will spark another surge.
7:32 a.m. Nov. 21, 2020 - By Ciara Linnane
U.S. moves closer to 200,000 daily COVID cases; Birx and Fauci urge Americans to follow safety measures over Thanksgiving Fauci at press briefing: ‘If you’re fighting a battle, and the cavalry is on the way, you don’t stop shooting. You keep going until the cavalry gets here.’The global case tally for the coronavirus illness COVID-19 climbed above 57 million on Friday, and the U.S. moved closer to 200,000 cases in a day and set a fresh record for hospitalizations as the virus continues to infect people in every state and region.
10:44 a.m. Nov. 17, 2020 - By Ciara Linnane
Coronavirus update: Republican governors are dropping resistance to face masks as infections soar and hospital beds fill ‘If Iowans don’t buy into this, we’ll lose. Businesses will close once again, more schools will be forced to go online, and our health-care system will fail,’ warns Gov. Kim ReynoldsThe global tally for the coronavirus illness COVID-19 rose above 55 million on Tuesday and the U.S. tally climbed above 11.2 million, with rising infections and shortages of hospital beds leading some Republican governors to drop their resistance to face masks and issue mandates.
Browse topics:

Filter results by

Location

Us (388)

Europe (79)

Asia Pacific (62)

Eu (54)

China (45)

Uk (15)

Link to MarketWatch's Slice.